Overview
Lankem Ceylon is a diversified chemicals, agro-inputs, paints, pest-control and consumer-products group. Its most important recent operating change was a substantial improvement in June-quarter profitability at the operating level, although this did not yet translate into a net profit.
The Group is also pursuing vertical integration in fertiliser through its SSP plant, adding a new manufacturing activity alongside its established import, distribution and branded-product operations.
Price performance
At LKR 36.00 on 2 September 2026, LCEY had fallen 11.6% over three months versus a 4.2% ASPI decline, and was down 21.1% over six months against a 10.3% fall in the index. The divergence is consistent with the operational and balance-sheet tension, although the filings and recent company news do not establish a cause for the share-price move.
The stock was only 2.3% up from its 52-week low. Trading volume was above its own 60-day norm, while 60-day volatility was below its own one-year level. Returns are restated for the October 2025 rights issue and December 2025 share split, so the much weaker as-traded one-year return should not be read as underlying investment performance.
Valuation
The loss-making position leaves P/E unavailable, while the annual return on equity was negative. At 0.858 times book value, LCEY trades below the diversified-holdings median of 1.31 times and sits at the 30th percentile of sector P/B observations.
The zero dividend yield offers no income offset, and no dividend history is supplied to establish a payout trend. The discount to book value needs to be read against continuing losses and a highly leveraged capital structure, rather than as a stand-alone valuation signal.
News and sentiment
Coverage was normal rather than unusually loud, with two material articles over 90 days: one positive and one neutral. The principal positive item was the 2 April disclosure of a LKR 3.0 billion investment in a 50,000-tonne-per-year SSP fertiliser plant; the reported target is to address up to 80% of domestic SSP demand.
A 30 July corporate disclosure concerned a corporate guarantee, but the supplied item does not quantify the exposure. The 1-for-3 rights issue became effective on 16 October 2025, followed by a 1-for-2 subdivision on 16 December 2025.
Financials
June-quarter revenue edged lower year-on-year, but operating profit more than doubled and the net loss narrowed. The improvement was operational, yet finance costs, tax, associates and foreign-exchange effects exceeded operating profit and kept the Group loss-making. Per-share comparisons are distorted by the rights issue and subsequent subdivision, which increased the share base.
Gross margin was 26.9% versus 21.1% a year earlier, operating margin was 4.9% versus 2.3%, and net margin was -1.6% versus -2.4%. Gross and net margins were among Lankem’s better June-quarter readings on the comparable group reporting basis, while operating margin was middling.
The twelve months to June 2026 produced broadly flat revenue, while the audited year to March 2026 remained loss-making. Equity attributable to owners was broadly unchanged over the latest two quarters, leaving the improvement in trading profitability insufficient to resolve the financing burden.
Risks
The principal risk is leverage: at March 2026, gearing was 308.5% of equity attributable to owners and interest cover was only 0.9 times. This leaves limited headroom if operating profitability weakens or borrowing costs remain elevated.
Liquidity is also tight, with a current ratio of 1.01, while operating cash conversion was -0.64 times and free cash flow was negative LKR 2.68 billion for the year. Minority interests accounted for 9.4% of annual profit or loss, meaning group earnings are not wholly attributable to the listed shareholders.
Manufacturing represents the larger part of reported segment revenue, and the sector backdrop as at 2 September 2026 showed softer July merchandise-export conditions despite an expanding manufacturing PMI. Fuel-driven inflation also raises potential input, distribution and consumer-demand pressure across the Group’s consumer-facing activities.
Outlook
As at 2 September 2026, the next scheduled disclosure is the quarter ending 30 September 2026, expected to be filed between 12 November 2026 and 2 March 2027. It should show whether the June operating improvement persisted and whether the loss-making position is narrowing further.
The data cannot quantify the SSP plant’s earnings contribution or the financial exposure under the July corporate guarantee. The next filing is therefore also the key source for assessing whether the new fertiliser investment is adding to operating capacity without worsening cash and financing pressure.